Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

被引：0
|
作者：
Wu, David
Emerson, Ryan
Sherwood, Anna
Loh, Mignon L.
Angiolillo, Anne
Kirsch, Ilan
Carlson, Christopher S.
Williamson, David
Wood, Brent L.
Robins, Harlan
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2550.2550
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2550
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
    Faham, Malek
    Zheng, Jianbiao
    Moorhead, Martin
    Carlton, Victoria
    Stow, Patricia Lee
    Coustan-Smith, Elaine
    Pui, Ching-Hon
    Campana, Dario
    BLOOD, 2012, 120 (21)
  • [32] NRP-1/CD304 Expression in Acute Leukemia A Potential Marker for Minimal Residual Disease Detection in Precursor B-Cell Acute Lymphoblastic Leukemia
    Meyerson, Howard J.
    Blidaru, Georgetta
    Edinger, Alison
    Osei, Ebenezer
    Schweitzer, Karen
    Fu, Pingfu
    Ho, Linda
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (01) : 39 - 50
  • [33] Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia Utility in Detection of Minimal Residual Disease by Flow Cytometry
    Muzzafar, Tariq
    Medeiros, L. Jeffrey
    Wang, Sa A.
    Brahmandam, Archana
    Thomas, Deborah A.
    Jorgensen, Jeffrey L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 692 - 698
  • [34] The importance of minimal residual disease for detection of late relapse in B-precursor acute lymphoblastic leukemia
    Virijevic, M.
    Kraguljac-Kurtovic, N.
    Pantic, N.
    Knezevic, V
    Mitrovic, M.
    HIPPOKRATIA, 2022, 26 (01) : 38 - 40
  • [35] Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood
    Mussolin, Lara
    Pillon, Marta
    Conter, Valentino
    Piglione, Matilde
    Lo Nigro, Luca
    Pierani, Paolo
    Micalizzi, Concetta
    Buffardi, Salvatore
    Basso, Giuseppe
    Zanesco, Luigi
    Rosolen, Angelo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5254 - 5261
  • [36] Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement
    Maloum, K
    Pritsch, O
    Dighiero, G
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (03) : 119 - 124
  • [37] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia (vol 131, pg 1522, 2018)
    Gokbuget, N.
    Dombret, H.
    Bonifacio, M.
    BLOOD, 2019, 133 (24) : 2625 - 2625
  • [38] EVALUATION OF NEW MARKERS FOR FLOW CYTOMETRIC MONITORING OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Sedek, L.
    Sonsala, A.
    Twardoch, M.
    Van der Velden, V. H.
    Orfao, A.
    Mejstrikova, E.
    Szczepanski, T.
    HAEMATOLOGICA, 2014, 99 : 544 - 545
  • [39] Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease
    Karsa, Mawar
    Dalla Pozza, Luciano
    Venn, Nicola C.
    Law, Tamara
    Shi, Rachael
    Giles, Jodie E.
    Bahar, Anita Y.
    Cross, Shamira
    Catchpoole, Daniel
    Haber, Michelle
    Marshall, Glenn M.
    Norris, Murray D.
    Sutton, Rosemary
    PLOS ONE, 2013, 8 (10):
  • [40] Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia
    Siami, K
    Awagu, S
    Cooper, DG
    Thomas, SA
    Huh, Y
    Jones, D
    Chen, W
    Jorgensen, JL
    MODERN PATHOLOGY, 2006, 19 : 246A - 247A
12345